About This Fund
Shibuya Kogyo is manufacturer of medical devices. In 2015, Cyfuse Biomedical K.K., the Japanese developer of a 3-D printer that produces human tissue sold a stake to 12 domestic investors including Shibuya Kogyo. Biomedical KK's Regenova three-dimensional printer, developed with Shibuya Kogyo, can be used to turn living cell aggregates into artificial human tissue. Such devices have applications for drugmakers and cosmetic companies seeking to test new products and could eventually be used to cut transplant rejections by constructing organs from a person’s own cells. Shibuya Kogyo is a part of the Shibuya Group which through its subsidiaries is involved in the The Shibuya Group provides Medical equipment systems, ,cleaning systems, Pharmaceutical and Regenerative medicine manufacturing systems, Robotic systems industries.
Investment Focus
What They Look For
primarily Japan-based, aged 4-5 years (avg. 10 years old at investment)
Preparing to pitch Shibuya Kogyo?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →